<DOC>
	<DOCNO>NCT00539396</DOCNO>
	<brief_summary>A 3 month , randomize , open label , multi-center study Technosphere/Insulin compare insulin aspart subject type 1 diabetes mellitus receive insulin glargine</brief_summary>
	<brief_title>A 3 Month , Randomized , Open Label , Multi-center Study Technosphere/Insulin Compared Insulin Aspart Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes currently receive SC insulin mealtime least 3 month BMI &lt; 40 kg/m square HbA1c great equal 7 % less equal 11.5 % Serum creatinine le 2 male less 1.8 female Acceptable pulmonary function Significant hepatic disease Previously diagnose pulmonary disease , ketoacidosis evidence severe secondary complication diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>